MacroGenics, Inc. - Common Stock (NQ:MGNX)

MGNX ALERT: Bragar Eagel & Squire, P.C. is Investigating Macrogenics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 10, 2024

MacroGenics to Participate in Upcoming Investor Conference

December 02, 2024

Peeling Back The Layers: Exploring Macrogenics Through Analyst Insights ↗

November 07, 2024

Via Benzinga

Macrogenics Earnings Preview ↗

November 04, 2024

Via Benzinga

Macrogenics Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗

September 18, 2024

Via Benzinga

MacroGenics to Participate in Upcoming Investor Conferences

November 06, 2024

MGNX earnings call for the period ending September 30, 2024.

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

MacroGenics (MGNX) Q3 2024 Earnings Call Transcript ↗

November 05, 2024

Via The Motley Fool

Topics Earnings

MacroGenics Announces Leadership Transition

October 30, 2024

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

October 29, 2024

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

October 22, 2024

From TerSera Therapeutics LLC

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

September 24, 2024

From The Schall Law Firm

MGNX DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 24 Deadline in Securities Class Action – MGNX

September 23, 2024

From The Rosen Law Firm PA

MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

September 23, 2024

From The Schall Law Firm

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm

September 21, 2024

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

September 19, 2024

From Faruqi & Faruqi LLP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm

September 17, 2024

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

September 17, 2024

From The Rosen Law Firm, P.A.

MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline

September 16, 2024

From Bernstein Liebhard LLP

Investor Reminder (MGNX): Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Investors of September 24, 2024 Deadline

September 16, 2024

From Kessler Topaz Meltzer & Check, LLP

MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024

September 15, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CAE, MacroGenics, Vicor, and American Airlines and Encourages Investors to Contact the Firm

September 13, 2024

Faruqi & Faruqi Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 - MGNX

September 13, 2024

From Faruqi & Faruqi LLP

Lead Plaintiff Deadline Quickly Approaching in MacroGenics, Inc. (MGNX) Class Action – Shareholders Should Contact Robbins LLP for Information

September 11, 2024

From Robbins LLP

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CAE, MacroGenics, Vicor, and American Airlines and Encourages Investors to Contact the Firm

September 09, 2024

MGNX INVETOR ALERT: Kirby McInerney LLP Reminds MacroGenics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

September 09, 2024

From Kirby McInerney LLP

MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline

September 09, 2024

From Bernstein Liebhard LLP

MacroGenics to host investor call to review key data presented at ESMO on Monday, September 16, 2024, at 8:00 a.m. ET

MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024

September 08, 2024

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

September 06, 2024

From Faruqi & Faruqi LLP